| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |